Phase III ADVANCE: 96-Wk Primary Efficacy Analysis of DTG + FTC/(TAF or TDF) vs EFV/FTC/TDF in ART-Naive PWH in South Africa

Watch this interactive presentation from CCO to see how clinicians use HIV-ASSIST to choose appropriate, guideline-based antiretroviral therapy

Jonathan Li, MD Maunank Shah, MD Physicians: maximum of 0.75 AMA PRA Category 1 Credits™ US Physicians: maximum of 0.75 Medical Knowledge MOC point(s) Registered Nurses: 0.75 Nursing contact hours Pharmacists: 0.75 contact hours (0.075 CEUs) Physician Assistants: maximum of 0.75 hours of AAPA Category I CME credits Released: February 4, 2021 Expired: February 3, 2022

Why Use HIV-ASSIST?

How HIV-ASSIST Works

Validation of the HIV-ASSIST Tool

Case 1: Initiating ART in a Treatment-Naive Patient

Case 2: Initiating ART in a Treatment-Naive Patient With Comorbidities and Drug–Drug Interactions

Case 3: Switching ART in a Treatment-Experienced Patient With Viremia and ARV Resistance Mutations

Download free expert-authored slides to see how clinicians use HIV-ASSIST to choose appropriate, guideline-based antiretroviral therapy

Jonathan Li, MD Maunank Shah, MD Released: February 4, 2021

Download CCO slides reviewing guidelines, key studies, and individual considerations for individualizing first-line ART regimens to treat HIV.

Joseph J. Eron, Jr., MD
Program Director Princy N. Kumar, MD, FIDSA, MACP
Program Director Daniel R. Kuritzkes, MD Released: February 4, 2021

Short video log from Rajesh Gandhi, MD, on the efficacy and safety of COVID-19 vaccines in older persons and persons with HIV

Rajesh T. Gandhi, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits™ Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 21, 2021 Expired: January 20, 2022